Plaintiffs' Request To Reinstate 13 Risperdal Cases
Plaintiffs' Request To Reinstate 13 Risperdal Cases
Introduction
Plaintiffs' request to reinstate 13 Risperdal gynecomastia cases was denied by a Pennsylvania state appeals panel agreeing with the trial judge that the claims were preempted by Michigan's drug shield law and that the plaintiffs could not prove that the fraud exception applied to their claims. Janssen Pharmaceuticals Inc. is the defendant named in this litigation.
Comments
Latest News
Walgreens Settles Federal Opioid Case for $300 Million
Categories: Opioids
Walgreens has agreed to pay $300 million to settle allegations by U.S. prosecutors that it unlawfully filled millions of invalid prescriptions for opioids and other controlled substances.
The U.S. Department of Justice announced on Monday…
Study: Opioid Use in Pregnancy May Shrink Newborn Brains
Categories: Opioids
New research from Children’s National Hospital in Washington, D.C., reveals that infants exposed to opioids in the womb have significantly smaller brain volumes than…
Suboxone Tooth Loss Lawsuits Reviewed at MDL Meeting
Categories: Opioids
The U.S. District Judge overseeing the federal Suboxone tooth decay multidistrict litigation (MDL) is scheduled to meet with attorneys tomorrow to assess the progress of pretrial proceedings and strategize on resolving over 11,000 product…